Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells DOI Open Access
Maria George Elias, Angelico D. Aputen, Shadma Fatima

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(15), С. 8252 - 8252

Опубликована: Июль 28, 2024

Chlorambucil-platinum(IV) prodrugs exhibit multi-mechanistic chemotherapeutic activity with promising anticancer potential. The platinum(II) precursors of the have been previously found to induce changes in microtubule cytoskeleton, specifically actin and tubulin HT29 colon cells, while chlorambucil alkylates DNA. These demonstrate significant 2D cell 3D spheroid viability assays. A notable production reactive oxygen species has observed cells 72 h post treatment this type, mitochondrial membrane potential was substantially reduced. cellular uptake chlorambucil-platinum(IV) prodrugs, assessed by ICP-MS, confirmed that active transport primary mechanism, platinum localisation identified primarily cytoskeletal fraction. Apoptosis necrosis were at as demonstrated Annexin V-FITC/PI assay using flow cytometry. Immunofluorescence measured via confocal microscopy showed intensity architecture. Western blot analysis intrinsic extrinsic pathway apoptotic markers, cytoskeleton proliferation well autophagy markers studied treatment. proteomic profile also a total 1859 proteins quantified mass spectroscopy, several dysregulated proteins. Network revealed dysregulation transcription, MAPK microtubule-associated dysfunction. This study confirms are candidates act chemotherapeutics.

Язык: Английский

A 4-Methylbenzoylhydrazine Pt(II) Complex Inhibits the Proliferation of Breast Cancer Cells by Regulating the Cell Cycle and Inducing Apoptosis DOI Creative Commons

Huiping Wang,

Xianguang Bai,

Yarui Li

и другие.

Inorganics, Год журнала: 2025, Номер 13(6), С. 177 - 177

Опубликована: Май 23, 2025

In this study, a novel 4-methylbenzoylhydrazide·dimethyl sulfoxide·dichloro platinum(II) complex (Pt2) was synthesized and characterized, its anti-tumor activity action mechanism were explored. The molecular structure spatial configuration of the determined using X-ray diffraction. results obtained fluorescence spectroscopy demonstrate that can effectively bind to DNA affect properties. experimental show Pt2 exhibited significant inhibitory effects on variety tumor cell lines (MCF-7, HepG-2, NCI-H460, T24, A549), IC50 values lower than those cisplatin (DDP), indicating stronger activity. addition, not only significantly induced apoptosis MCF-7 cells but also inhibited cycle arrest at G2 phase, with proportion G2-phase as high 49.47%. conclusion, 4-methylbenzoylhydrazide exhibits good by inducing inhibiting cycle, providing an important basis for development platinum-based drugs.

Язык: Английский

Процитировано

0

Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP) DOI

K. Jagathesan,

Sovan Roy

ChemMedChem, Год журнала: 2024, Номер 19(14)

Опубликована: Апрель 18, 2024

Hypoxia is a state characterized by low concentration of Oxygen. Hypoxic often found in the central region solid tumors. associated with abnormal neovascularization resulted poor blood flow tissues and increased proliferation tumor cells, imbalance between O

Язык: Английский

Процитировано

2

Omeprazole-Loaded Copper Nanoparticles for Mitochondrial Damage Mediated Synergistic Anticancer Activity against Melanoma Cells DOI
Kalyani Eswar,

Sri Amruthaa Sankaranarayanan,

Rupali Srivastava

и другие.

ACS Applied Bio Materials, Год журнала: 2024, Номер 7(7), С. 4795 - 4803

Опубликована: Июль 3, 2024

Metallic nanoparticles are promising candidates for anticancer therapies. Among the different metallic systems studied, copper is an affordable and biologically available metal with a high redox potential. Copper-based widely used in studies owing to their ability react intracellular glutathione (GSH) induce Fenton-like reaction. However, considering metastatic potential versatility of tumor microenvironment, modalities single therapeutic agent may not be effective. Hence, enhance efficiency chemotherapeutic drugs, repurposing them or conjugating other essential. Omeprazole FDA-approved proton pump inhibitor clinics treatment ulcers. has also been studied its sensitize cancer cells chemotherapy apoptosis. Herein, we report nanosystem comprising encapsulating omeprazole (CuOzL) against B16 melanoma cells. The developed nanoformulation exerted significant synergistic activity when compared either alone by inducing cell death through excessive ROS generation subsequent mitochondrial damage.

Язык: Английский

Процитировано

2

Co-targeting CDK 4/6 and C-MYC/STAT3/CCND1 axis and inhibition of tumorigenesis and epithelial-mesenchymal-transition in triple negative breast cancer by Pt(II) complexes bearing NH3 as trans-co-ligand DOI

Zhimin Lv,

Amjad Ali, Na Wang

и другие.

Journal of Inorganic Biochemistry, Год журнала: 2024, Номер 259, С. 112661 - 112661

Опубликована: Июль 6, 2024

Язык: Английский

Процитировано

2

Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells DOI Open Access
Maria George Elias, Angelico D. Aputen, Shadma Fatima

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(15), С. 8252 - 8252

Опубликована: Июль 28, 2024

Chlorambucil-platinum(IV) prodrugs exhibit multi-mechanistic chemotherapeutic activity with promising anticancer potential. The platinum(II) precursors of the have been previously found to induce changes in microtubule cytoskeleton, specifically actin and tubulin HT29 colon cells, while chlorambucil alkylates DNA. These demonstrate significant 2D cell 3D spheroid viability assays. A notable production reactive oxygen species has observed cells 72 h post treatment this type, mitochondrial membrane potential was substantially reduced. cellular uptake chlorambucil-platinum(IV) prodrugs, assessed by ICP-MS, confirmed that active transport primary mechanism, platinum localisation identified primarily cytoskeletal fraction. Apoptosis necrosis were at as demonstrated Annexin V-FITC/PI assay using flow cytometry. Immunofluorescence measured via confocal microscopy showed intensity architecture. Western blot analysis intrinsic extrinsic pathway apoptotic markers, cytoskeleton proliferation well autophagy markers studied treatment. proteomic profile also a total 1859 proteins quantified mass spectroscopy, several dysregulated proteins. Network revealed dysregulation transcription, MAPK microtubule-associated dysfunction. This study confirms are candidates act chemotherapeutics.

Язык: Английский

Процитировано

2